1. “REGISTRATION COMORBIDITY IN PATIENTS WITH SARCOIDOSIS AND PROGNOSTIC IMPLICATIONS, DATA COLLECTION MODEL ON A SPANISH REGIONAL HOSPITAL.”  S. Martín Guillén(1) R. Hurtado García (1), A. Álvarez de Cienfuegos (2). (1)Internal Medicine, (2) Rheumatology. Hospital Vega Baja, Alicante, Spain.
OBJECTIVES
Charlson´s index is a system for assessing life expectancy at ten years following, depending on the age at which it is evaluated, and comorbidities of the subject. In addition to age, consisting of 19 items, which if present, it has been found that influence of a concrete form in the subject's life expectancy. Initially adapted for surviving a year, was finally adapted into shape for survival at 10 years. We propose their use in a registry of sarcoidosis and the prognostic implications in assessing tracking patients.
METHODS AND MATERIAL
We collect data from 14 patients diagnosed with sarcoidosis in our department over the past 5 years. A retrospective study was performed. We discard 1 patient´s missing data. We collect data on vascular risk such as LDL cholesterol, HDL cholesterol, triglycerides, diabetes, Hypertension and some other demographic variables. Charlson test conducted on all patients and evaluated survival at 10 years; we also collect mortality data in the sample. We performed statistical analysis using SPSS v 18
RESULTS Female gender was more frequent (53.84 %). In our sample, the mean Charlson index score was 5.80 with a median survival of 10 years shows a %. Mortality was 38.5%. 46.2% had hypertension and 38, 5% were diabetes mellitus. The lipids profile results were: total cholesterol 167, 85 mg/dl, HDL c 38, 60 mg/dl, triglycerides 159, 92 mg/dl and LDLc 97, 50 mg/dl. CONCLUSIONS Sarcoidosis comorbidities, especially vascular high risk factors, were some of the most important contributors to hospital mortality and resource utilization.